- Home
- AEON vs MLSS Comparison
AEON vs MLSS Comparison
Compare AEON & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEON | MLSS |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 22.1M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | AEON | MLSS |
|---|---|---|
| Price | $0.89 | $0.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.20 | $1.00 |
| AVG Volume (30 Days) | 69.5K | ★ 220.9K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,973,982.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | N/A | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $0.38 | $0.22 |
| 52 Week High | $1.45 | $1.11 |
Technical Indicators
Market Signals| Indicator | AEON | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 54.23 |
| Support Level | $0.87 | $0.24 |
| Resistance Level | $1.12 | $0.30 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 12.07 | 68.39 |
Price Performance
Historical ComparisonAbout AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.